TAE Technologies Announces First Subsidiary Company for Life Sciences with Potential to Reshape the World of Oncology
TAE Life Sciences leverages fusion energy breakthroughs to provide technology for a promising, investigative cancer treatment.
TAE Life Sciences leverages fusion energy breakthroughs to provide technology for a promising, investigative cancer treatment.
February 2018 | J.A. Romero | Nature Communications | Paper
Active control of field reversed configuration (FRC) devices requires a method to determine the flux surface geometry and dynamic properties of the plasma during both transient and steady-state conditions.
CEO Steven Specker said TAE may have other spin-off companies up its sleeve as the company works to make its fusion dream come true. “We like the word ‘disruptive.’”
The need for safe, sustainable, limitless energy is as great now as it’s ever been, both to mitigate climate concerns and because creating clean energy resources raises global living standards for everyone. Access to clean energy, particularly in developing countries, leads to economic equality, energy independence, job creation and overall geopolitical stability.
CEO Steven Specker said TAE may have other spin-off companies up its sleeve as the company works to make its fusion dream come true. “We like the word ‘disruptive.’”